Legal Expertise Since 1995

Expert Legal Advice 0161 832 5000

Health Supplements

Posted by Andrew Stripe on November 19th 2010
(Deal Lab, Investment Opportunities)

Background: To exploit a unique Swiss developed formulation developing, selling, marketing and distributing a range of health supplements.

IPR jointly owed with Swiss partner.

Two clinically proven products already available in major healthcare retailers and selected multiples aimed at alleviating irritable bowel syndrome and improving immunity from colds, flu and other ailments.

Funded to date by research grants and shareholders.

Approximately £1m of equity investment is sought to accelerate PR and marketing and the development of an internet sales proposition.

Ref: NO10 120

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News

21 Jan
What is a Statutory Demand?

A statutory demand is a written demand for payment of a debt, in a prescribed form, served on either: An individual, in accordance with section 268(1)(a) of the Insolvency Act 1986 (IA 1986). A company, in accordance with section 123(1)(a) or 222(1)(a) of the IA 1986. This practice note provides more detail (Statutory demands and […]

View More

What Clients Say

“Right from the inset Stripes listened to our business requirements, especially for an early stage business, then provided a flexible and commercial approach that enabled NWIX to scale our needs alongside our growth path.

Above all Stripes are always professional, deliver on time and offer a pragmatic approach.”

John Ridd, NWIX Group Ltd View More